Traders should monitor for potential downward pressure on ANIP shares, especially given the breadth of selling across the executive team. The absence of any offsetting insider buying and the concentration of sales among C-suite leaders may signal reduced confidence ahead of earnings or regulatory developments.
Price Chart
Executive Summary
Seven corporate insiders at ANI Pharmaceuticals sold shares in the past week, including five open-market sales totaling $1.23 million and four non-cash tax withholding transactions totaling $2.14 million. The selling involved key executives, including the CEO, CFO, and multiple SVPs, with open-market dispositions representing approximately 0.08% of the company's $1.6B market cap.
Key Financial Metrics
Key Facts
- Five open-market sales by senior executives totaling $1,228,501.87 in the past 7 days
- CEO Lalwani Nikhil did not sell shares directly but had 17,060 shares withheld for taxes ($1.26M value)
- CFO Carey and other SVPs also had shares withheld for taxes, adding $872,043.12 in non-cash dispositions
- Total insider share dispositions (cash + non-cash) in cluster: $3.37 million
- Open-market selling was distributed across multiple executives in established brands, rare disease, HR, and legal
- No insider purchases were reported in the cluster
Financial Impact
$1.23 million in open-market sales and $2.14 million in tax-related share surrenders over 7 days
Risk Factors
- Perception of insider pessimism due to coordinated timing of sales
- Potential for further selling if executives are exiting positions systematically
- Market reaction could amplify on light volume given the relatively small float typical in specialty pharma
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (9 trades, 7d window) | cluster-ANIP-1773437352172 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $72.11 $77.91 | ▲ +8.04% | ▲ +7.23% | $71.97 (−0.19%) |
Sep 1, 2026 4w ago | Insider Cluster | $73.06 $71.46 | ▼ −2.19% | ▼ −1.23% | $71.97 (−1.49%) |
Aug 24, 2026 5w ago | 8-K | $74.17 $73.25 | ▼ −1.24% | ▼ −1.71% | $71.97 (−2.97%) |
Aug 13, 2026 7w ago | Insider Cluster | $74.77 $77.32 | ▲ +3.41% | ▲ +5.37% | $71.97 (−3.74%) |
Aug 7, 2026 8w ago | 8-K | $78.25 $76.54 | ▼ −2.19% | ▼ −2.58% | $71.97 (−8.03%) |
Jul 16, 2026 11w ago | Court Ruling | $81.92 $78.53 | ▼ −4.14% | ▼ −2.47% | $71.97 (−12.15%) |
Jul 13, 2026 11w ago | Press Release | $81.08 $79.20 | ▼ −2.32% | ▼ −1.53% | $71.97 (−11.24%) |
Jun 15, 2026 15w ago | Insider Cluster | $83.00 $82.94 | ▼ −0.07% | ▲ +2.16% | $71.97 (−13.29%) |
Jun 11, 2026 16w ago | Insider Cluster | $81.65 $80.52 | ▼ −1.38% | ▼ −1.82% | $71.97 (−11.86%) |
May 21, 2026 19w ago | 8-K | $82.72 $76.71 | ▼ −7.27% | ▼ −8.92% | $71.97 (−13.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access